These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 20699106)

  • 41. Chronic administration of antipsychotics attenuates ongoing and ketamine-induced increases in cortical γ oscillations.
    Anderson PM; Pinault D; O'Brien TJ; Jones NC
    Int J Neuropsychopharmacol; 2014 Nov; 17(11):1895-904. PubMed ID: 24964190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prenatal treatment with methylazoxymethanol acetate as a neurodevelopmental disruption model of schizophrenia in mice.
    Takahashi K; Nakagawasai O; Sakuma W; Nemoto W; Odaira T; Lin JR; Onogi H; Srivastava LK; Tan-No K
    Neuropharmacology; 2019 May; 150():1-14. PubMed ID: 30831160
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychopharmacological study of agmatine in behavioral tests of schizophrenia in rodents.
    Kotagale NR; Taksande BG; Wadhwani PJ; Palhade MW; Mendhi SM; Gawande DY; Hadole PN; Chopde CT
    Pharmacol Biochem Behav; 2012 Jan; 100(3):398-403. PubMed ID: 21989253
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is Forced Swimming Immobility a Good Endpoint for Modeling Negative Symptoms of Schizophrenia? - Study of Sub-Anesthetic Ketamine Repeated Administration Effects.
    Neves G; Borsoi M; Antonio CB; Pranke MA; Betti AH; Rates SMK
    An Acad Bras Cienc; 2017; 89(3):1655-1669. PubMed ID: 28832723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of acute and long-term typical or atypical neuroleptics on morphine-induced behavioural effects in mice.
    Hollais AW; Patti CL; Zanin KA; Fukushiro DF; Berro LF; Carvalho RC; Kameda SR; Frussa-Filho R
    Clin Exp Pharmacol Physiol; 2014 Mar; 41(3):255-63. PubMed ID: 24471703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
    Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
    Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative effects of sertraline, haloperidol or olanzapine treatments on ketamine-induced changes in mouse behaviours.
    Onaolapo OJ; Paul TB; Onaolapo AY
    Metab Brain Dis; 2017 Oct; 32(5):1475-1489. PubMed ID: 28508340
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping the central effects of chronic ketamine administration in an adolescent primate model by functional magnetic resonance imaging (fMRI).
    Yu H; Li Q; Wang D; Shi L; Lu G; Sun L; Wang L; Zhu W; Mak YT; Wong N; Wang Y; Pan F; Yew DT
    Neurotoxicology; 2012 Jan; 33(1):70-7. PubMed ID: 22178134
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haloperidol and risperidone have specific effects on altered pain sensitivity in the ketamine model of schizophrenia.
    Becker A; Grecksch G; Zernig G; Ladstaetter E; Hiemke C; Schmitt U
    Psychopharmacology (Berl); 2009 Mar; 202(4):579-87. PubMed ID: 18810393
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors.
    Hołuj M; Popik P; Nikiforuk A
    Behav Pharmacol; 2015 Dec; 26(8 Spec No):766-75. PubMed ID: 25769091
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: possible involvement of an antioxidant effect.
    de Araújo FY; de Oliveira GV; Gomes PX; Soares MA; Silva MI; Carvalho AF; de Moraes MO; de Moraes ME; Vasconcelos SM; Viana GS; de Sousa FC; Macêdo DS
    J Pharm Pharmacol; 2011 Aug; 63(8):1103-10. PubMed ID: 21718294
    [TBL] [Abstract][Full Text] [Related]  

  • 52. N-methyl-d-aspartic acid receptor antagonist-induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia.
    Ehrlichman RS; Gandal MJ; Maxwell CR; Lazarewicz MT; Finkel LH; Contreras D; Turetsky BI; Siegel SJ
    Neuroscience; 2009 Jan; 158(2):705-12. PubMed ID: 19015010
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Enhancement of immobility in a forced swimming test by subacute or repeated treatment with phencyclidine: a new model of schizophrenia.
    Noda Y; Yamada K; Furukawa H; Nabeshima T
    Br J Pharmacol; 1995 Nov; 116(5):2531-7. PubMed ID: 8581295
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cannabidiol and clozapine reverse MK-801-induced deficits in social interaction and hyperactivity in Sprague-Dawley rats.
    Gururajan A; Taylor DA; Malone DT
    J Psychopharmacol; 2012 Oct; 26(10):1317-32. PubMed ID: 22495620
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Methionine-Induced Animal Model of Schizophrenia: Face and Predictive Validity.
    Wang L; Alachkar A; Sanathara N; Belluzzi JD; Wang Z; Civelli O
    Int J Neuropsychopharmacol; 2015 May; 18(12):. PubMed ID: 25991655
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Olfactory deficit as a result of clozapine withdrawal syndrome in an animal model of schizophrenia: preliminary results.
    Pacheco FD; Silva MLD; Batista G; Santos W; Castro AA; Canever L; Zugno AI
    An Acad Bras Cienc; 2018; 90(2):1659-1663. PubMed ID: 29898114
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
    Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
    Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differential effects of haloperidol, clozapine and olanzapine on learning and memory functions in mice.
    Hou Y; Wu CF; Yang JY; Guo T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1486-95. PubMed ID: 16842896
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative behavioural effects of typical and atypical antipsychotic drugs in rhesus monkey.
    Kumar R; Palit G; Dhawan BN
    Eur J Pharmacol; 2003 Feb; 462(1-3):133-8. PubMed ID: 12591105
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential effect of spermidine on GABA, dopamine, acetylcholinesterase, oxidative stress and proinflammatory cytokines to diminish ketamine-induced psychotic symptoms in rats.
    Yadav M; Parle M; Jindal DK; Sharma N
    Biomed Pharmacother; 2018 Feb; 98():207-213. PubMed ID: 29268241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.